Hospital groups want to intervene in opposition to three more drug manufacturers' lawsuits against the federal government over 340B contract pharmacy requirements.

Hospitals Want Role in Three More Pharma Lawsuits Over 340B Contract Pharmacy

Hospital groups that recently filed a motion to intervene in opposition to drug manufacturer Eli Lilly’s lawsuit against the federal government over 340B contract pharmacy requirements also are trying to intervene in similar suits against the government by manufacturers AstraZeneca, Novo Nordisk, and Sanofi.

The six groups—American Hospital Association (AHA), 340B Health, America’s Essential Hospitals, the Association of American Medical Colleges (AAMC), Children’s Hospital Association (CHA), and ASHP (American Society of Health-System Pharmacists)—on Friday jointly filed a motion to intervene in AstraZeneca’s lawsuit in federal district court in Delaware. On Tuesday, they similarly filed motions in federal court in New Jersey in Sanofi’s and Novo Nordisk’s lawsuits. Lilly’s case is being heard in Indianapolis.

Hospital groups that recently filed a motion to intervene in opposition to drug manufacturer Eli Lilly’s lawsuit against the federal government over 340B contract pharmacy requirements also are trying to intervene in similar suits against the government by manufacturers AstraZeneca, Novo Nordisk, and Sanofi.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer